Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
CRNX
Crinetics Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for CRNX
Full CRNX profile on Quantisnow Follow CRNX and get a push notification the moment its next story breaks.